Effect of Oseltamivir on Catecholamines and Select Oxidative Stress Markers in the Presence of Oligoelements in the Rat Brain

다국어 초록 (Multilingual Abstract)

The effect that osteltamivir has on the metabolism of catecholamines and oxidative damage in the brains of young patients remains unclear. The purpose of this study was to measure the effects of oseltamivir, in the presence of oligoelements, on biogenic amines and select oxidative biomarkers in the brains of uninfected, young rats under normal conditions. The study was conducted using male Wistar rats intraperitoneally treated for three days with either a control dose of 0.9 % NaCl, oseltamivir (50 mg/kg), oligoelements (50 μL/rat), or oseltamivir (50 mg/kg) and oligoelements (50 μL/rat). The brain tissue extracted from the treated rats was used to determine the concentrations of adrenaline, noradrenaline, and dopamine, as well as the levels of GSH, lipid peroxidation, and ATPase activity. An increase in the concentration of adrenaline and noradrenaline and in the level of GSH in the group treated with oligoelements (p < 0.001) was observed, while the group treated with oseltamivir and oligoelements, the levels of dopamine increased (p < 0.001), and in the groups treated with oligoelements alone or combination with oseltamivir a decrease in lipid peroxidation was observed (p < 0.001). The results of this study suggest that the consumption of oseltamivir and oligoelements induce biphasic changes in the metabolism of catecholamines; thereby, inducing a protective mechanism against oxidative damage in the brains of young rats.

참고문헌 (Reference)

1 Bediz, C. S, "Zinc supplementation ameliorates electromagnetic fieldinduced lipid peroxidation in the rat brain" 208 : 133-140, 2006

2 Pifl, C, "Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner" 56 : 531-540, 2009

3 Gutteridge, J. M, "The measurement and mechanism of lipid peroxidation in biological systems" 15 : 129-135, 1990

4 Neault, J. F, "The effects of anions on the solution structure of Na,K-ATPase" 19 : 95-102, 2001

5 Fiske, C. H, "The colorimetric determination of phosphorus" 66 : 375-400, 1925

6 "The Biochemical Pathways Charts"

7 Muñoz, C. J, "Role of serotonin in cerebral oxidative stress in rats" 66 : 1-6, 2006

8 Ju, T. C, "Protective effects of S-nitrosoglutathione against amyloid beta-peptide neurotoxicity" 38 : 938-949, 2005

9 Johanson, C. E, "Permeability and vascularity of the developing brain: cerebellum vs cerebral cortex" 190 : 3-16, 1980

10 Oshima, S, "Penetration of oseltamivir and its active metabolite into the brain after lipopolysaccharide-induced inflamma- tion in mice" 61 : 1397-1400, 2009

11 Morimoto, K, "Oseltamivir (Tamiflu)efflux transport at the blood-brain barrier via P-Glycoprotein" 36 : 6-9, 2008

12 Yoshino, T, "Oseltamivir (Tamiflu) increases dopamine levels in the rat medial prefrontal cortex" 438 : 67-69, 2008

13 Madrigal, J. L, "Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta" 103 : 2092-2101, 2007

14 Izumi, Y, "Neuroexcitatory actions of Tamiflu and its carboxylate metabolite" 426 : 54-58, 2007

15 Kacergius, T, "Neuraminidase inhibitors reduce nitric oxide production in influenza virus-infected and gamma interferonactivated RAW 264.7 macrophages" 58 : 924-930, 2006

16 Thompson, W. W, "Mortality associated with influenza and respiratory syncytial virus in the United States" 289 : 179-186, 2003

17 Alanis-Guzman, M. G, "Mineral composition of milk produced in Monterrey, N. L. Mexico" 42 : 456-459, 1992

18 Swapna, I, "Membrane alterations and fluidity changes in cerebral cortex during ammonia intoxication Neuro" 335 : 700-704, 2005

19 Erikson, K. M, "Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity" 97 : 459-466, 2007

20 Henche-Morilla, A. L, "Levels of oligo-elements and trace elements in patients at the time of admission in intensive care units" 5 : 338-344, 1990

21 Brase, D. A, "Is intracellular sodium involved in the mechanism of tolerance to opioid drugs?" 32 : 161-167, 1990

22 Sigma-Aldrich, "HPLC applications drugs"

23 Castilla-Serna, L, "Estadística simplificada para la investigación en Ciencias de la Salud. Editorial Trillas. 1o Edición" Editorial Trillas 1991

24 Calderón-Guzmán, D, "Effect of toluene and nutritional status on serotonin, lipid peroxidation levels and Na+/K+-ATPase in adult rat brain" 30 : 619-624, 2005

25 Benuck, M, "Effect of food deprivation on glutathione and amino acid levels in brain and liver of young and aged rats" 678 : 259-264, 1995

26 Ozcelik, D, "Copper intoxication; antioxidant defenses and oxidative damage in rat brain" 127 : 45-52, 2009

27 Chen, M. T, "Brain lipid peroxidation and changes of trace metals in rats following chronic manganese chloride exposure" 65 : 305-316, 2002

28 Toovey, S, "Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review" 31 : 1097-1114, 2008

29 Beckman, J. S, "Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxides" 87 : 1620-1624, 1990

30 Gülçin, I, "Antioxidant activity of L-adrenaline: a structureactivity insight" 179 : 71-80, 2009

31 Fuke, C, "Analysis of oseltamivir active metabolite, oseltamivir carboxylate, in biological materials by HPLC-UV in a case of death following ingestion of Tamiflu" 10 : 83-87, 2008

32 Driver, A. S, "Agerelated changes in reactive oxygen species production in rat brain homogenates" 22 : 175-181, 2000

33 Hernández, R. J, "A serotonin agonist-antagonist reversible effect on Na+, K+-ATPase activity in the developing rat brain" 5 : 326-331, 1982

34 Hissin, P. J, "A fluorometric method for determination of oxidized and reduced glutathione in tissues" 74 : 214-226, 1976